Giuseppe Cicala

639 total citations
32 papers, 405 citations indexed

About

Giuseppe Cicala is a scholar working on Surgery, Toxicology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Giuseppe Cicala has authored 32 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Toxicology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Giuseppe Cicala's work include Pharmacovigilance and Adverse Drug Reactions (9 papers), Pharmaceutical studies and practices (8 papers) and Gastroesophageal reflux and treatments (3 papers). Giuseppe Cicala is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (9 papers), Pharmaceutical studies and practices (8 papers) and Gastroesophageal reflux and treatments (3 papers). Giuseppe Cicala collaborates with scholars based in Italy, United States and Spain. Giuseppe Cicala's co-authors include Edoardo Spina, María Antonietta Barbieri, José de León, Paola Maria Cutroneo, Emanuela Elisa Sorbara, Claudio Romano, Valeria Dipasquale, Vincenzo Arcoraci, Vincenza Santoro and Tindara Franchina and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Pharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Giuseppe Cicala

32 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppe Cicala Italy 14 102 59 52 52 49 32 405
Gianluca Trifirò Netherlands 7 106 1.0× 71 1.2× 28 0.5× 19 0.4× 24 0.5× 8 532
Michele Tari Italy 13 54 0.5× 37 0.6× 44 0.8× 73 1.4× 21 0.4× 26 615
Pipasha Biswas United Kingdom 10 63 0.6× 137 2.3× 33 0.6× 29 0.6× 59 1.2× 15 528
Stephen P. Motsko United States 11 75 0.7× 13 0.2× 98 1.9× 71 1.4× 61 1.2× 23 637
Francesco Giorgianni Italy 13 45 0.4× 28 0.5× 28 0.5× 19 0.4× 39 0.8× 24 451
Mohit Sodhi Canada 10 48 0.5× 12 0.2× 107 2.1× 42 0.8× 21 0.4× 28 544
Yeon‐Hee Baek South Korea 11 30 0.3× 42 0.7× 46 0.9× 27 0.5× 59 1.2× 24 256
Leila Chebane France 11 34 0.3× 67 1.1× 27 0.5× 30 0.6× 21 0.4× 26 285
Judith Cottin France 10 41 0.4× 16 0.3× 35 0.7× 28 0.5× 19 0.4× 23 286
H. Karl Greenblatt United States 8 30 0.3× 25 0.4× 45 0.9× 25 0.5× 19 0.4× 10 231

Countries citing papers authored by Giuseppe Cicala

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Cicala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Cicala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Cicala more than expected).

Fields of papers citing papers by Giuseppe Cicala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Cicala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Cicala. The network helps show where Giuseppe Cicala may publish in the future.

Co-authorship network of co-authors of Giuseppe Cicala

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Cicala. A scholar is included among the top collaborators of Giuseppe Cicala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Cicala. Giuseppe Cicala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbieri, María Antonietta, Giulia Russo, Giuseppe Cicala, et al.. (2025). Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System. European Journal of Clinical Pharmacology. 81(5). 755–770. 1 indexed citations
2.
Cicala, Giuseppe, Giovanni Pallio, Natasha Irrera, et al.. (2024). Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database. Pharmaceuticals. 17(10). 1365–1365. 4 indexed citations
3.
Cicala, Giuseppe, Giulia Russo, Vincenza Santoro, et al.. (2024). Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System. Pharmaceuticals. 17(10). 1266–1266. 2 indexed citations
4.
Cicala, Giuseppe, María Antonietta Barbieri, Giulia Russo, Francesco Salvo, & Edoardo Spina. (2024). Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data. Pharmaceuticals. 17(3). 342–342. 3 indexed citations
5.
Lombardo, Nicola, et al.. (2023). Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis. Journal of Personalized Medicine. 14(1). 3–3. 10 indexed citations
6.
Lombardi, Niccolò, Maria Giuseppa Sullo, Edoardo Spina, et al.. (2023). Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study. Journal of Clinical Medicine. 12(23). 7447–7447. 1 indexed citations
7.
Cicala, Giuseppe, Renato de Filippis, María Antonietta Barbieri, et al.. (2023). Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database. Frontiers in Psychiatry. 14. 1130636–1130636. 5 indexed citations
8.
Barbieri, María Antonietta, Giulia Russo, Emanuela Elisa Sorbara, et al.. (2023). Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System. Frontiers in Oncology. 13. 1268672–1268672. 6 indexed citations
9.
Barbieri, María Antonietta, Emanuela Elisa Sorbara, Giuseppe Cicala, et al.. (2022). Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database. Frontiers in Pharmacology. 13. 808370–808370. 13 indexed citations
10.
Dipasquale, Valeria, Giuseppe Cicala, Edoardo Spina, & Claudio Romano. (2022). Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence. Frontiers in Pharmacology. 13. 846151–846151. 3 indexed citations
11.
Barbieri, María Antonietta, Emanuela Elisa Sorbara, Giuseppe Cicala, et al.. (2022). Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database. Frontiers in Oncology. 12. 1005626–1005626. 18 indexed citations
12.
Dipasquale, Valeria, Giuseppe Cicala, Edoardo Spina, & Claudio Romano. (2022). A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children. Frontiers in Pharmacology. 13. 839972–839972. 31 indexed citations
13.
Dipasquale, Valeria, Giuseppe Cicala, Paola Maria Cutroneo, et al.. (2022). Spontaneous reporting of adverse reactions related to proton pump inhibitors. Digestive and Liver Disease. 55(5). 595–600. 2 indexed citations
14.
Franco, Valentina, María Antonietta Barbieri, Paola Maria Cutroneo, et al.. (2021). Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019). Epilepsy & Behavior. 119. 107989–107989. 16 indexed citations
15.
Barbieri, María Antonietta, Paola Maria Cutroneo, Chiara Baratelli, et al.. (2021). Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database. Journal of Clinical Pharmacy and Therapeutics. 46(4). 1027–1040. 9 indexed citations
16.
Barbieri, María Antonietta, Emanuela Elisa Sorbara, Giuseppe Cicala, et al.. (2021). Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database. Drugs - Real World Outcomes. 9(1). 91–107. 23 indexed citations
17.
Squadrito, Francesco, Natasha Irrera, Letteria Minutoli, et al.. (2020). Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude. Biomedicine & Pharmacotherapy. 128. 110320–110320. 18 indexed citations
18.
Cicala, Giuseppe, María Antonietta Barbieri, Vincenza Santoro, et al.. (2020). Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study. Frontiers in Psychiatry. 11. 152–152. 15 indexed citations
19.
Barbieri, María Antonietta, Giuseppe Cicala, Paola Maria Cutroneo, et al.. (2019). Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database. Frontiers in Pharmacology. 10. 1161–1161. 24 indexed citations
20.
Barbieri, María Antonietta, Giuseppe Cicala, Maria Gioffré‐Florio, et al.. (2019). Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study. BMC Pharmacology and Toxicology. 20(1). 21–21. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026